Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endocrine Disorders and Peripheral Arterial Disease - A Series of Reviews Cushing Syndrome-Cortisol Excess.

Current vascular pharmacology·2023
Same author

Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency.

Current vascular pharmacology·2023
Same author

Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.

Digestive diseases and sciences·2021
Same author

Multifocal arterial disease: clinical implications and management.

Current opinion in cardiology·2020
Same author

Preface.

Current vascular pharmacology·2018
Same author

Daylight saving time and myocardial infarction: should we be worried? A review of the evidence.

European review for medical and pharmacological sciences·2018

Related Experiment Video

Updated: Jul 13, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Dyslipidemia as a risk factor for erectile dysfunction.

G E Vrentzos1, K I Paraskevas, D P Mikhailidis

  • 1Department of Clinical Biochemistry (Vascular Disease Prevention Clinic), Royal Free Hospital and Royal Free University College Medical School, London NW3 2QG, UK.

Current Medicinal Chemistry
|July 14, 2007
PubMed
Summary

Erectile dysfunction (ED) is linked to cardiovascular risk factors like dyslipidemia, which impairs nitric oxide (NO) activity. Treating high cholesterol with statins may improve ED and indicate underlying vascular issues.

Related Experiment Videos

Last Updated: Jul 13, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Area of Science:

  • Cardiovascular Medicine
  • Urology
  • Endocrinology

Background:

  • Erectile dysfunction (ED) significantly impacts quality of life and its prevalence increases with age and comorbidities.
  • Risk factors such as hypertension, diabetes, smoking, and dyslipidemia adversely affect nitric oxide (NO) activity in penile and vascular tissues.
  • Endothelial dysfunction and reduced NO bioavailability are key pathophysiological mechanisms in ED.

Purpose of the Study:

  • To explore the link between dyslipidemia and erectile dysfunction.
  • To investigate the role of hyperlipidemia and cholesterol levels in erectile function.
  • To assess the potential benefits of treating dyslipidemia on ED.

Main Methods:

  • Review of literature on the pathophysiology of ED and its relation to cardiovascular risk factors.
  • Analysis of the impact of hyperlipidemia, oxidized low-density lipoprotein, and cholesterol levels on penile endothelial and smooth muscle cells.
  • Examination of evidence regarding the efficacy of statins in managing ED and their potential role in patients with vascular disease.

Main Results:

  • Hyperlipidemia impairs erectile function by affecting penile endothelial and smooth muscle cells.
  • Elevated serum cholesterol and reduced high-density lipoprotein cholesterol are associated with increased ED risk.
  • Statins may improve responses to phosphodiesterase type 5 inhibitors and benefit patients with ED as a sign of vascular disease.

Conclusions:

  • Dyslipidemia is a significant contributor to erectile dysfunction through mechanisms involving endothelial dysfunction and reduced NO bioavailability.
  • Treating dyslipidemia, potentially with statins, may offer a beneficial therapeutic strategy for ED.
  • ED serves as an important indicator of silent or early-stage vascular disease, highlighting the importance of cardiovascular risk assessment.